Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Learn what questions to ask a financial advisor as a new investor. Empower yourself with the right information for success.
27,223 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Lumentum’s stock surged 1,000% over the past year as AI-driven demand for high-power lasers accelerates. A BNP Pariba...
As Nvidia prepares to report earnings in May, investors weigh AI momentum against valuation. This practical guide exp...
Bitcoin faces a fresh test as sentiment cools despite a modest near-term upside. Markets monitor whether BTC can recl...
Nvidia sits at a pivotal crossroads as driverless technology could next reshape how auto tech and AI collide. This ar...
Relai CEO Julian Liniger says the AI buildout is soaking up liquidity, weighing bitcoin demand in the near term while...
Sotheby’s hosts its inaugural AI-generated artwork sale, featuring the Ai-Da robot painting a portrait of Alan Turing...
The Virtus InfraCap U.S. Preferred Stock ETF trades near $21 with a 9.9% forward yield built on leverage and high-cou...
Lynx Investment Advisory recently disclosed a meaningful stake in the Akre Focus ETF, signaling confidence in a quali...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
Snow-season demand shapes profitability for snow equipment makers. This article breaks down douglas dynamics (plow) e...
Binance unveils new cross-margin pairs for DOGE, ADA and other altcoins, alongside selective delistings. Traders resp...